Genetic polymorphism of the human organic solute carrier protein 1 (hOSCP1) gene in Japanese patients with non-viral liver carcinoma

Anwar, 2008, Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention, Mutat. Res., 659, 176, 10.1016/j.mrrev.2008.01.005 Bartosch, 2009, Hepatitis C virus-induced hepatocarcinogenesis, J. Hepatol., 51, 810, 10.1016/j.jhep.2009.05.008 Blonski, 2010, Non-viral causes of hepatocellular carcinoma, World J. Gastroenterol., 16, 3603, 10.3748/wjg.v16.i29.3603 Caldwell, 2004, The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease, J. Hepatol., 40, 578, 10.1016/j.jhep.2004.02.013 Chang, 2011, SLC25A13 gene mutations in Taiwanese patients with non-viral hepatocellular carcinoma, Mol. Genet. Metab., 103, 293, 10.1016/j.ymgme.2011.03.013 Colombo, 1992, Hepatocellular carcinoma, J. Hepatol., 15, 225, 10.1016/0168-8278(92)90041-M De Bac, 1994, Pathogenetic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study, Hepatology, 20, 1225, 10.1002/hep.1840200519 Donato, 2002, Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women, Am. J. Epidemiol., 15, 323, 10.1093/aje/155.4.323 El-Serag, 2004, Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma, Gastroenterology, 126, 460, 10.1053/j.gastro.2003.10.065 Evans, 1999, Pharmacogenomics: translating functional genomics into rational therapeutics, Sciences, 286, 487, 10.1126/science.286.5439.487 Hamed, 2013, Non-viral factors contributing to hepatocellular carcinoma, World J. Hepatol., 27, 311, 10.4254/wjh.v5.i6.311 Hoffmeyer, 2000, Functional polymorphisms of the human multidrug-resistance gene multiple sequence variations and correlation of one allele with P glycoprotein expression and activity in vivo, Proc. Natl. Acad. Sci. U. S. A., 97, 3473, 10.1073/pnas.97.7.3473 Ichida, 2008, Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese, Clin. Genet., 74, 243, 10.1111/j.1399-0004.2008.01021.x Izuno, 2007, Rat organic solute carrier protein 1 (rOscp1) mediated the transport of organic solutes in Xenopus laevis oocytes: isolation and pharmacological characterization of rOscp1, Life Sci., 81, 1183, 10.1016/j.lfs.2007.08.012 Kerb, 2006, Implications of genetic polymorphisms in drug transporters for pharmacotherapy, Cancer Lett., 234, 4, 10.1016/j.canlet.2005.06.051 Kiyosawa, 1990, Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus, Hepatology, 12, 671, 10.1002/hep.1840120409 Kobayashi, 2005, Isolation and Functional Characterization of a Novel Organic Solute Carrier Protein, hOSCP1, J. Biol. Chem., 280, 32332, 10.1074/jbc.M504246200 Kobayashi, 2007, Isolation and characterization of polyspecific mouse organic solute carrier protein 1 (mOscp1), Drug Metab. Dispos., 35, 1239, 10.1124/dmd.107.014795 Kudo, 2014, Mitochondrial metabolism in the noncancerous liver determine the occurrence of hepatocellular carcinoma: a prospective study, J. Gastroenterol., 49, 502, 10.1007/s00535-013-0791-4 Lockhart, 2003, Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy, Mol. Cancer Ther., 2, 685 Marrero, 2005, Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma, J. Hepatol., 42, 218, 10.1016/j.jhep.2004.10.005 Nie, 2003, Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line, J. Cancer Res. Clin. Oncol., 129, 410, 10.1007/s00432-003-0451-9 Nishizato, 2003, Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics, Clin. Pharmacol. Ther., 73, 554, 10.1016/S0009-9236(03)00060-2 Okuda, 1992, Hepatocellular carcinoma: recent progress, Hepatology, 15, 948, 10.1002/hep.1840150532 Parkin, 2005, Global cancer statistics, 2002, CA Cancer J. Clin., 55, 74, 10.3322/canjclin.55.2.74 Polesel, 2007, Nutrients intake and the risk of hepatocellular carcinoma in Italy, Eur. J. Cancer, 43, 2381, 10.1016/j.ejca.2007.07.012 Qian, 1994, A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China, Cancer Epidemiol. Biomarkers Prev., 3, 3 Siccardi, 2010, Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521T>C polymorphism, Pharmacogenet. Genomics, 20, 759, 10.1097/FPC.0b013e3283402efb Tanaka, 1991, Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population, Cancer Res., 51, 2842 VanWert, 2010, Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology, Biopharm. Drug Dispos., 31, 1 Wolk, 2001, A prospective study of obesity and cancer risk (Sweden), Cancer Causes Control, 12, 13, 10.1023/A:1008995217664 Yasui, 2014, Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study, Oncology, 86, 53, 10.1159/000356643